Zahra Saberi

Zahra Saberi

Auto-generated profile, based on publicly available information

Zahra Saberi

Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LNLaleh Naghibi
Laleh Naghibi
MYMona Yazdani
Mona Yazdani
AMAmir Abbas Momtazi-Borojeni
Amir Abbas Momtazi-Borojeni
ARAtefeh Razazan
Atefeh Razazan
SSSheida Shariat
Sheida Shariat
MJMahmoud Reza Jaafari
Mahmoud Reza Jaafari
HER2/neu is an immunogenic protein inducing both humoral and cell-mediated immune responses. The antigen-specific cytotoxic T lymphocytes (CTLs) are the main effector immune cells in the anti-tumor immunity. To induce an effective CTL specific response against P5+435 single peptide derived from rat HER2/neu oncogene, we used a liposome delivery vehicle.In vivoenhancement of liposome stability and intracytoplasmic delivery of peptides are the main strategies which elevate the liposome-mediated drug delivery. Liposomes containing high transition temperature phospholipids, such as DSPC, are stable with prolongedin vivocirculation and more accessibility to the immune system. Incorporation of DOPE phospholipid results in the effective delivery of peptide into the cytoplasmviathe endocytotic pathway. To this end, the P5+435 peptide was linked to Maleimide-PEG2000-DSPE and coupled on the surface of nanoliposomes containing DSPC: DSPG: Cholesterol with/without DOPE. We observed that mice vaccinated with Lip-DOPE-P5+435 formulation had the highest number of IFN-γ- producing CTLs with the highest cytotoxic activity that consequently led to significantly smallest tumor size and prolonged survival rate in the TUBO mice model. In conclusion, our study indicated that the liposomal form of P5+435 peptide containing DOPE can be regarded as a promising prophylactic anti-cancer vaccine to generate potent antigen-specific immunity.

12 June 2024 in International Immunopharmacology
Verified
Journal Article
Closed access
RKRahimeh Khoshkhabar
Rahimeh Khoshkhabar
MYMona Yazdani
Mona Yazdani
SASeyedeh Hoda Hoda Alavizadeh
Seyedeh Hoda Hoda Alavizadeh
ZSZahra Saberi
Zahra Saberi
LALeila Arabi
Leila Arabi
MJMahmoud Reza Jaafari
Mahmoud Reza Jaafari

27 October 2020 in Current Drug Delivery
Verified
Journal Article
Closed access
PDF file
OCOmid Chavoshian
Omid Chavoshian
MAMahdieh Arabsalmani
Mahdieh Arabsalmani
MJMahmoud Reza Jaafari
Mahmoud Reza Jaafari
AKAli Khamesipour
Ali Khamesipour
AAAzam Abbasi
Azam Abbasi
ABAli Badiee
Ali Badiee
Aim: This study aimed to investigate the existence of phospholipase-A (PLA) activity in Soluble L. major Antigens (SLA) because of no reports for it so far. Liposomes were used as sensors to evaluate PLA activity. Objective: Liposomal SLA consisting of Egg Phosphatidylcholine (EPC) or Sphingomyelin (SM) were prepared by two different methods in different pH or temperatures and characterized by Dynamic Light Scattering (DLS) and Thin Layer Chromatography (TLC). Methods: Lipid hydrolysis led to the disruption of EPC liposomal SLA in both methods but the Film Method (FM) produced more stable liposomes than the Detergent Removal Method (DRM). Results: The preparation of EPC liposomal SLA at pH 6 via FM protected liposomes from hydrolysis to some extent for a short time. EPC liposomes but not SM liposomes were disrupted in the presence of SLA. Conclusion: Therefore, a phospholipid without ester bond such as SM should be utilized in liposome formulations containing PLA as an encapsulating protein.